CleveMed’s Home Sleep Testing Solutions cross The 100,000 Studies Mark

May 3, 2018

Healthcare providers across the US have used CleveMed’s SleepView technology and fulfillment services in over 100,000 home sleep tests to date.

CleveMed, Cleveland, OH – May 3, 2018 – CleveMed’s technologies and services that best link primary care physicians with sleep specialists to address the diagnostic needs of their patients just crossed a major milestone. Healthcare providers across the US have used CleveMed’s SleepView technology and fulfillment services in over 100,000 home sleep tests to date. “We are very excited about this milestone”, said Sarah Weimer, CleveMed’s Director of Sleep Products and Services. “The growth is driven by our success in connecting various stakeholders together. Our cloud-based technologies connect sleep physicians with primary care sources to speed test ordering, while our mail order services improve the fulfillment of those tests. Both tools share the ultimate goal of enhancing patient access to sleep apnea care”.

“Unlike other national home sleep testing companies, CleveMed’s technologies and services improve patient access while retaining oversight by sleep physicians and labs for improved care continuity. Sleep specialists are now able to not only better compete in their own markets but expand their reach like never before”, said Dr. Tim Kowalski, CleveMed medical director.

CleveMed’s SleepView is the smallest and lightest sleep monitor on the market that exceeds the American Academy of Sleep Medicine guidelines. Its mail order program has been growing at double digit rate every month for the past 5 quarters.

Obstructive sleep apnea (OSA), the most prevalent form of sleep apnea, is a repeated interruption of normal breathing during sleep due to a collapse of the upper airway. It is estimated to impact as many people as asthma and diabetes; yet, up to 80 percent of the population with the disease remain undiagnosed and untreated. Moreover, OSA leads to serious health and economic consequences. Numerous studies link OSA to major chronic diseases such as stroke, heart failure, diabetes, obesity, hypertension and increased odds of serious car crash injuries.

CleveMed is a fast growing company with a wide range of sleep testing equipment, services, and cloud based technologies that allow sleep disorders to be monitored in the home, including Sapphire PSG™, SleepScout TM, SleepView®, SleepViewSM Web-portal, and SleepView Direct. CleveMed’s goal is to expand the reach of sleep medicine with technologies that speed diagnosis for providers, reduce healthcare costs for payers, and improve patients’ experiences in the home. For more information, please visit www.CleveMed.com (Follow us on twitter, youtube, LinkedIn, and facebook). SleepView is a registered trademark and a service mark, and Sapphire PSG and SleepScout are trademarks of Cleveland Medical Devices Inc. of Cleveland, OH.